Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports
- PMID: 10093064
- DOI: 10.1016/s0960-8966(98)00088-1
Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports
Abstract
Clinical studies of facioscapulohumeral muscular dystrophy (FSHD) rarely report muscle pain as a significant feature of the condition. We report four adult patients with FSHD in whom muscle pain was a presenting complaint and remains their most disabling symptom. These four patients were investigated using a pain questionnaire and diary. Inflammatory and metabolic causes of muscle pain were sought by muscle biopsy and a range of biochemical investigations. All patients reported between three and seven different pains of varying site and nature. None of the group had more than one painfree day per month and all complained of disturbed sleep. While some pains could potentially be attributed to postural problems, others were clearly myalgic in nature, though most often not specifically exercise-related. These myalgic pains could be particularly difficult to control. Results of metabolic investigations and muscle biopsy revealed no clue to the pathogenesis of these pains and there was no evidence for any exceptional inflammatory response. We believe that pain in FSHD is an under-reported but significant symptom and that further work is necessary to determine its prevalence, understand its cause and provide effective treatment.
Similar articles
-
Early-onset facioscapulohumeral muscular dystrophy: two case reports.Brain Dev. 1997 Dec;19(8):563-7. doi: 10.1016/s0387-7604(97)00083-1. Brain Dev. 1997. PMID: 9440803
-
Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.Clin Chim Acta. 2018 Mar;478:171-181. doi: 10.1016/j.cca.2017.12.036. Epub 2017 Dec 24. Clin Chim Acta. 2018. PMID: 29278724
-
Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.Muscle Nerve Suppl. 1995;2:S56-66. Muscle Nerve Suppl. 1995. PMID: 7739627
-
Muscular dystrophies and other genetic myopathies.Neurol Clin. 2013 Nov;31(4):1009-29. doi: 10.1016/j.ncl.2013.04.004. Neurol Clin. 2013. PMID: 24176421 Review.
-
[Facioscapulohumeral muscular dystrophy (FSHD)].Nihon Rinsho. 1997 Dec;55(12):3181-5. Nihon Rinsho. 1997. PMID: 9436432 Review. Japanese.
Cited by
-
Chronic pain in neuromuscular disease: pain site and intensity differentially impacts function.Phys Med Rehabil Clin N Am. 2012 Nov;23(4):895-902. doi: 10.1016/j.pmr.2012.08.008. Epub 2012 Oct 17. Phys Med Rehabil Clin N Am. 2012. PMID: 23137744 Free PMC article. Review.
-
Quality of life in adults with muscular dystrophy.Health Qual Life Outcomes. 2019 Jul 15;17(1):121. doi: 10.1186/s12955-019-1177-y. Health Qual Life Outcomes. 2019. PMID: 31307472 Free PMC article.
-
[Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].Nervenarzt. 2011 Jun;82(6):712-22. doi: 10.1007/s00115-010-2968-x. Nervenarzt. 2011. PMID: 21567298 German.
-
Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy.Clin J Pain. 2012 Jan;28(1):47-54. doi: 10.1097/AJP.0b013e31822019b1. Clin J Pain. 2012. PMID: 21642844 Free PMC article.
-
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.J Neurol. 2007 Jul;254(7):931-40. doi: 10.1007/s00415-006-0432-4. Epub 2007 Mar 14. J Neurol. 2007. PMID: 17361345 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical